Aktienanalyse zu DENTSPLY SIRONA Inc (XRAY)XRAYDENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

DENTSPLY SIRONA Inc (XRAY) is currently priced at $8.57, which is significantly below the analyst price targets ranging from $10 to $15. However, the stock has seen a year-to-date decline of 23.96% and a 1-year change of -33.72%, indicating ongoing struggles. The RSI is at 42.278, suggesting it is nearing oversold territory, but the MACD indicates bearish momentum. The forward P/E ratio is 6.33, which may suggest undervaluation, yet the company has reported mixed earnings with a gross margin of 54.90% in Q2 2026, showing some operational resilience. The main risk is the negative net income trend, with a net loss of $10 million in Q1 2026 and $37 million in Q2 2026, which could impact future performance.

13 analysts cover XRAY: 8 rate it Buy, 4 Hold and 1 Sell. The average price target is 13.04.